| Melissa E. Murray, Ph.D., co-investigator; Nilufer Ertekin-Taner, M.D., Ph.D., contact principal investigator |
Centrally-Linked Longitudinal Peripheral Biomarkers of AD in Multiethnic Populations: Project 1 |
NIA |
03/2023 to 03/2028 |
| Melissa E. Murray, Ph.D., principal investigator |
Quantitative Neuropathologic Evaluation and AI Computational Modeling of Tau Isoforms |
Rainwater Charitable Foundation |
11/2023 to 08/2024 |
| Melissa E. Murray, Ph.D., co-investigator; Wilfried O. Rossoll, Ph.D., contact principal investigator |
Capturing the Molecular Complexity of Tau Pathology-Associated Proteomes Involved in the Etiology of Alzheimer's Disease and Related Dementias |
NIA |
09/2022 to 07/2027 |
| Melissa E. Murray, Ph.D., Program Director, principal investigator |
Investigating Regional and Cellular Vulnerabilities to Tau Pathology in Young-Onset Alzheimer's Disease |
NIA |
02/2022 to 11/2026 |
| Melissa E. Murray, Ph.D., co-principal investigator |
Tau PET/CT for Early Detection of Alzheimer's Disease Pathology |
NIA |
09/2021 to 05/2026 |
| Melissa E. Murray, Ph.D., co-principal investigator of Core C and co-investigator of Project 3; Takahisa Kanekiyo, M.D., Ph.D., contact principal investigator |
Biology and Pathobiology of ApoE in Aging and Alzheimer's Disease |
NIA |
09/2021 to 05/2026 |
| Melissa E. Murray, Ph.D., co-investigator; Jonathan Graff-Radford, M.D., contact principal investigator |
What is N? Toward Operationalizing Neurodegeneration in Alzheimer's and Related Dementias |
NIA |
04/2021 to 03/2024 |
| Melissa E. Murray, Ph.D., co-investigator; Jonathan Graff-Radford, Ph.D., contact principal investigator |
ADRC Jacksonville Consortiums Years 21-25 |
NIA |
07/2019 to 04/2024 |
| Melissa E. Murray, Ph.D., co-principal investigator of Neuropathology Core |
Early-Onset AD Consortium — The LEAD Study (LEADS) |
NIA |
09/2019 to 05/2024 |